Posts related to ‘BIIB’

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

Posted: July 23, 2010 at 2:15 pm

Genzyme Corporation (NASDAQ: GENZ) is flying high on reports that Sanofi-Aventis (NYSE: SNY) may have an interest in buying the company. The WSJ reports that the large drug giant has ...
Read Full Story »

More Big Drug & Biotech Mergers Likely (SNY, AMGN, BIIB, GENZ, BSX, JNJ, HGSI, DNDN, AUXL, VRTX, AMLN, LLY, WCRX, CBST)

Posted: July 6, 2010 at 2:24 pm

Sanofi-Aventis SA (NYSE: SNY) was a bit of a stalking horse news item on a week that many investors and traders started taking off for a long weekend. The company ...
Read Full Story »

Opportunity Knocks: Turning Around 3 Large Biotechs (AMGN, BIIB, GENZ)

Posted: June 2, 2010 at 2:17 pm

Biotech is the land of promise for emerging players. It is also the land of stagnation for well established and sturdy giants. Amgen, Inc. (NASDAQ: AMGN), Biogen Idec Inc. (NASDAQ: ...
Read Full Story »

BioHealth Business Daily (ACUR, AMLN, BIIB, ELN, CADX, CYCC, HGSI, MIPI, PRAN, RNN, SQNM)

Posted: April 20, 2010 at 3:14 pm

Today's version of the BioHealth Business Daily is again full of stocks on the move with news, and some not on news. Array BioPharma, Inc. (NASDAQ: ARRY), BioDelivery Services International ...
Read Full Story »

BioHealth Business Daily (ACUR, AMLN, BIIB, ELN, CADX, CYCC, HGSI, MIPI, PRAN, RNN, SQNM)

Posted: April 19, 2010 at 3:20 pm

Today's version of the BioHealth Business Daily has many stocks moving on news, but oddly many of the real news stocks are hardly moving and were eliminated from today's report. ...
Read Full Story »

Today’s Best Market Rumors (3/23/2010)

Posted: March 23, 2010 at 7:47 am

Updated thoughout the day. Carl Icahn will push for the sale of Biogen (BIIB) (Bloomberg) Buffett's Berkshire Hathaway (BRK.B) may be more liquor distributors after picked up Empire (Bloomberg) Nintendo ...
Read Full Story »

BioHealth Business Daily (CTIC, DNDN, MNKD, VPHM, SOMX, SQNM, TEVA, RNN, BIIB)

Posted: March 22, 2010 at 12:57 pm

Monday is seeing many winners and losers in the healthcare sector on the heels of the health care reform passage in the House of Representatives this weekend. We are focusing ...
Read Full Story »

Top 10 Analyst Upgrades and Downgrades (ABT, ARO, BIIB, CELG, CADC, FACT, HBC, LMNX, EDU, SGI)

Posted: March 12, 2010 at 8:38 am

These are this Friday’s top analyst upgrades, downgrades, and initiations seen from Wall Street morning research calls: Abbott Laboratories (NYSE: ABT) Cut to Sell at Citigroup. Aeropostale (NYSE: ARO) Raised ...
Read Full Story »

Top 10 Analyst Upgrades and Downgrades (BIIB, CMA, ENER, ESLR, FSLR, MAT, HK, TRV, YUM, ZRAN)

Posted: March 9, 2010 at 8:17 am

These are this Tuesday morning's top analyst upgrades, downgrades, and initiations seen in early Wall Street research notes: Biogen Idec (NASDAQ: BIIB) Started as Buy at Soleil. Comerica (NYSE: CMA) ...
Read Full Story »

Unusual Options Trading Alerts (AAPL, GOOG, AMZN, RIMM, GLD, BIIB, MU)

Posted: December 21, 2009 at 1:42 pm

We have compiled several options chains we are watching today now that the DEC-2009 PUTS/CALLS have expired on Friday. Much of this likely options roll-outs continuing, but we are seeing ...
Read Full Story »

Top 10 Analyst Upgrades, Downgrades, Initiations (BIIB, INCY, MOT, CMCSA, JWN, ODP, PALM, RIMM, RCL, YUM)

Posted: November 2, 2009 at 9:25 am

These are this Monday's top ten analyst upgrades, downgrades, and initiations seen from Wall Street research firms: Biogen Idec (NASDAQ: BIIB) Raised to Buy at Jefferies. Incyte Corporation (NASDAQ: INCY) ...
Read Full Story »

BioTech Hostile Takeover: Biogen Plays For Facet

Posted: September 4, 2009 at 3:48 pm

Facet Biotech Corporation (FACT) confirms that it is in receipt of Biogen Idec Inc.'s (BIIB) letter dated September 4, 2009 offering $14.50 per share for all of the outstanding shares ...
Read Full Story »

Top Analyst Upgrades and Downgrades (BIIB, FRX, GENZ, GILD, HOLX, LVS, MOS, NVAX, RIG, TXT)

Posted: September 2, 2009 at 8:21 am

These are the top ten analyst research initiations, upgrades, and downgrades we have seen from top Wall Street firms early this Wednesday morning: Biogen-Idec (BIIB) Started as Underperform at BofA/Merrill ...
Read Full Story »

When Key Biotechs Have Low P/E’s & Value Screens (AMGN, BIIB, CEPH, CBST, GENZ, PDLI)

Posted: August 24, 2009 at 9:54 am

It usually takes an event or a series of events for biotech stocks to ever look cheap compared to the overall market or even to sub-sectors within health care. They ...
Read Full Story »

Media Digest 8/7/2009 Reuters, WSJ, NY Times, FT, Bloomberg

Posted: August 7, 2009 at 4:05 am

Reuters: A college education no longer means easy employment in China. Reuters: Fannie Mae (FNM) lost $14.8 billion. Reuters: The auto "clunkers" legislation passed the Senate. Reuters: Obama is in ...
Read Full Story »

Categories:
- 24/7 Wall St. Wire (3376)
- Accounting (283)
- Activist Investor (250)
- ADR (534)
- Aerospace (111)
- After-Hours Activity (98)
- Agriculture (260)
- Airlines (303)
- Analyst Calls (2698)
- Annual Report (63)
- Apparel (208)
- Austerity (33)
- auto (15)
- Autos (1162)
- Bait Shop (91)
- Banking (1663)
- Bankruptcy (202)
- Biotech (726)
- Blogs (5)
- Bonds (384)
- Brokerage Firms (437)
- Buffett (301)
- Buffett Holdings (31)
- business and finance (27)
- Business Services (177)
- Cable Companies (128)
- Calendar (226)
- Casinos (67)
- Charts (107)
- China (857)
- Commodities (636)
- Compensation (309)
- Conglomerates (424)
- Consumer Electronics (1098)
- Consumer Goods (502)
- Corporate Governance (491)
- Cramer (728)
- Cult Stock (191)
- Currency (127)
- Defense (75)
- Defensive Stocks (116)
- Dividend (512)
- Drug companies (276)
- Earnings (2938)
- Earnings Warning (447)
- Economy (2465)
- Editor's Picks (458)
- Emerging Markets (195)
- Entertainment (570)
- ETF (532)
- Exchange (43)
- Exchange News (121)
- FDA (90)
- Financial Stocks (1182)
- Food (592)
- General (3668)
- Green Biz (878)
  - Alternative Energy (838)
- Hardware (207)
- Healthcare (173)
- HI/LOW (711)
- Housing (679)
- Index (288)
- Industry (157)
  - Technology (117)
    - Semiconductors (38)
- Infrastructure (197)
- Insider Activity (217)
- International Markets (2079)
- Internet (1720)
- Interview (53)
- IPOs (998)
- Labor & Unions (451)
- Large Cap Stocks (129)
- Law (404)
- Luxury (156)
- Management Change (629)
- Market Close (159)
- Market Open (191)
- Market Roundups (40)
- Media (861)
- Medical (238)
- Mergers and Buy Outs (1868)
- Metals (460)
- Micro Cap (7)
- Most Actives (31)
- Mutual Funds (224)
- Nanotech (8)
- Newsletter (7)
- Nuclear (74)
- Oil & Gas (1855)
- Old Media (206)
- Options (106)
- OTC (25)
- PC Companies (613)
- Personal Finance (79)
- Pharmaceuticals (227)
- Politics (567)
- Polls (23)
- Pre-Market Activity (757)
- Press Digest (1350)
- Private Equity (432)
- Product Review (62)
- Regulation (472)
- REIT (89)
- Research (1586)
- Restatements (23)
- Retail (1255)
- Rumors (876)
- Satellite (273)
- SEC (164)
- Secondary Offering (529)
- Semiconductor (638)
- Shareholder Issues (475)
- Short Interest (326)
- Small Cap Stocks (20)
- Software (766)
- Special Report (125)
- Stock Buybacks (173)
- Stock Splits (60)
- Tax (86)
- Technical Analysis (99)
- Technology Companies (1340)
- Telecom (657)
- The Day (84)
- The Week (148)
- Tobacco (47)
- Trading Alert (960)
- Transports (250)
- Turnarounds (210)
- TV (86)
- Utilities (283)
- Value Investing (330)
- Video Games (204)
- Water (55)
- WiMAX (164)
- Wireless (966)

24/7 Wall St. - Insightful Analysis and Commentary for U.S. and Global Equity Investors

Posts related to ‘BIIB’

Looking at Genzyme’s Peers for ‘Other Buyout Candidate’ Probabilities (GENZ, SNY, GILD, CELG, BIIB, LIFE, HGSI, DNDN)

More Big Drug & Biotech Mergers Likely (SNY, AMGN, BIIB, GENZ, BSX, JNJ, HGSI, DNDN, AUXL, VRTX, AMLN, LLY, WCRX, CBST)

Opportunity Knocks: Turning Around 3 Large Biotechs (AMGN, BIIB, GENZ)

BioHealth Business Daily (ACUR, AMLN, BIIB, ELN, CADX, CYCC, HGSI, MIPI, PRAN, RNN, SQNM)

BioHealth Business Daily (ACUR, AMLN, BIIB, ELN, CADX, CYCC, HGSI, MIPI, PRAN, RNN, SQNM)

Today’s Best Market Rumors (3/23/2010)

BioHealth Business Daily (CTIC, DNDN, MNKD, VPHM, SOMX, SQNM, TEVA, RNN, BIIB)

Top 10 Analyst Upgrades and Downgrades (ABT, ARO, BIIB, CELG, CADC, FACT, HBC, LMNX, EDU, SGI)

Top 10 Analyst Upgrades and Downgrades (BIIB, CMA, ENER, ESLR, FSLR, MAT, HK, TRV, YUM, ZRAN)

Unusual Options Trading Alerts (AAPL, GOOG, AMZN, RIMM, GLD, BIIB, MU)

Top 10 Analyst Upgrades, Downgrades, Initiations (BIIB, INCY, MOT, CMCSA, JWN, ODP, PALM, RIMM, RCL, YUM)

BioTech Hostile Takeover: Biogen Plays For Facet

Top Analyst Upgrades and Downgrades (BIIB, FRX, GENZ, GILD, HOLX, LVS, MOS, NVAX, RIG, TXT)

When Key Biotechs Have Low P/E’s & Value Screens (AMGN, BIIB, CEPH, CBST, GENZ, PDLI)

Media Digest 8/7/2009 Reuters, WSJ, NY Times, FT, Bloomberg

Categories:

Recent Posts